Latest filings (excl ownership)
8-K
Departure of Directors or Certain Officers
26 Apr 24
ARS
2023 FY
Annual report to shareholders
24 Apr 24
DEFA14A
Additional proxy soliciting materials
24 Apr 24
DEF 14A
Definitive proxy
24 Apr 24
10-K/A
2023 FY
Annual report (amended)
22 Mar 24
S-8
Registration of securities for employees
11 Mar 24
10-K
2023 FY
Annual report
5 Mar 24
8-K
IO Biotech Announces 2023 Fourth-Quarter and Year-End Results
5 Mar 24
8-K
Regulation FD Disclosure
8 Jan 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
8-K
IO Biotech Announces 2023 Third Quarter Results
13 Nov 23
424B2
Prospectus for primary offering
12 Sep 23
EFFECT
Notice of effectiveness
11 Sep 23
CORRESP
Correspondence with SEC
6 Sep 23
UPLOAD
Letter from SEC
6 Sep 23
S-3
Shelf registration
30 Aug 23
10-Q
2023 Q2
Quarterly report
11 Aug 23
8-K
IO Biotech Announces 2023 Second Quarter Results
11 Aug 23
8-K
IO Biotech, Inc. Announces $75 Million Private Placement Financing
7 Aug 23
8-K
IO Biotech Strengthens Executive Management and US Presence with Appointment of Qasim Ahmad, MD, as Chief Medical Officer
18 Jul 23
8-K
IO Biotech Announces Achievement of Significant Phase 3 Clinical Trial Recruitment Milestone
14 Jun 23
8-K
Submission of Matters to a Vote of Security Holders
9 Jun 23
10-Q
2023 Q1
Quarterly report
11 May 23
8-K
IO Biotech Announces 2023 First-Quarter Results
11 May 23
ARS
2022 FY
Annual report to shareholders
26 Apr 23
DEFA14A
Additional proxy soliciting materials
26 Apr 23
DEF 14A
Definitive proxy
26 Apr 23
8-K
Departure of Directors or Certain Officers
20 Apr 23
PRE 14A
Preliminary proxy
14 Apr 23
10-K
2022 FY
Annual report
14 Mar 23
8-K
IO Biotech Announces 2022 Fourth-Quarter and Year-End Results
14 Mar 23
8-K
Results of Operations and Financial Condition
14 Mar 23
8-K
Regulation FD Disclosure
10 Mar 23
8-K
Other Events
15 Feb 23
424B2
Prospectus for primary offering
15 Feb 23
EFFECT
Notice of effectiveness
13 Feb 23
CORRESP
Correspondence with SEC
9 Feb 23
UPLOAD
Letter from SEC
8 Feb 23
S-8
Registration of securities for employees
6 Feb 23
S-3
Shelf registration
3 Feb 23
Latest ownership filings
144
Notice of proposed sale of securities
10 May 24
4
Mai-Britt Zocca
18 Mar 24
4
Amy Sullivan
18 Mar 24
4
Devin Whittemore Smith
18 Mar 24
4
Brian Burkavage
18 Mar 24
4
Qasim Iftikhar Ahmad
18 Mar 24
SC 13G/A
Avoro Capital Advisors LLC
14 Feb 24
SC 13D/A
Novo Holdings A/S
13 Feb 24
4
Change in insider ownership
13 Feb 24
SC 13G/A
BANK OF AMERICA CORP /DE/
13 Feb 24
SC 13G/A
Stonepine Capital Management, LLC
13 Feb 24
SC 13G/A
HBM Healthcare Investments (Cayman) Ltd.
13 Feb 24
144
Notice of proposed sale of securities
9 Feb 24
SC 13G
Samsara BioCapital, L.P.
18 Dec 23
4
Brian Burkavage
24 Nov 23
4
Helen Louise Collins
17 Nov 23
3
Helen Louise Collins
17 Nov 23
SC 13G
Kurma Partners
7 Sep 23
3
Initial statement of insider ownership
21 Aug 23
SC 13G
Stonepine Capital Management, LLC
16 Aug 23
4
Heidi Hunter
15 Aug 23
3
Heidi Hunter
15 Aug 23
SC 13G/A
HBM Healthcare Investments (Cayman) Ltd.
15 Aug 23
SC 13G/A
HBM Healthcare Investments (Cayman) Ltd.
14 Aug 23
SC 13D/A
Lundbeckfond Invest A/S
14 Aug 23
4
Christian E Elling
11 Aug 23
4
Invest A/S Lundbeckfond
11 Aug 23
SC 13D/A
Novo Holdings A/S
11 Aug 23
4
Change in insider ownership
11 Aug 23
4
Change in insider ownership
10 Aug 23
4
Mai-Britt Zocca
9 Aug 23
4
Amy Sullivan
9 Aug 23
4
Devin Whittemore Smith
9 Aug 23
4
Qasim Iftikhar Ahmad
19 Jul 23
3
Qasim Iftikhar Ahmad
19 Jul 23
4
David V Smith
13 Jun 23
4
Jack Nielsen
13 Jun 23
4
Peter Hirth
13 Jun 23
4
Kathleen Sereda Glaub
13 Jun 23
4
Christian E Elling
13 Jun 23